Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Diane 35 plus finasteride is more effective for treating hirsutism.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Flutamide reduces hair growth better but has more side effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Finasteride can cause serious side effects in some men, needing more research for treatment.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A woman developed male traits from accidental contact with her husband's testosterone gel.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.